Free Graft Augmentation Urethroplasty for Bulbar Urethral Strictures: Which Technique Is Best? A Systematic Review.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
07 2021
Historique:
received: 20 11 2020
accepted: 24 03 2021
pubmed: 21 4 2021
medline: 19 2 2022
entrez: 20 4 2021
Statut: ppublish

Résumé

Four techniques for graft placement in one-stage bulbar urethroplasty have been reported: dorsal onlay (DO), ventral onlay (VO), dorsolateral onlay (DLO), and dorsal inlay (DI). There is currently no systematic review in the literature comparing these techniques. To assess if stricture recurrence and secondary outcomes vary between the four techniques and to assess if one technique is superior to any other. The EMBASE, MEDLINE, and Cochrane Systematic Reviews-Cochrane Central Register of Controlled Trials (CENTRAL; Cochrane HTA, DARE, HEED) databases and ClinicalTrials.gov were searched for publications in English from 1996 onwards. Randomised controlled trials (RCTs), nonrandomised comparative studies (NRCSs), observational studies (cohort, case-control/comparative, single-arm), and case series with ≥20 adult male participants were included. A total of 41 studies were included involving 3683 patients from one RCT, four NRCSs, and 36 case series. Owing to the overall low quality of the evidence, a narrative synthesis was performed. No single technique appears to be superior to another for bulbar free graft urethroplasty. Both DO and VO are suitable for bulbar augmentation urethroplasty, with a ≤20% recurrence rate over medium-term follow-up. No recommendations can be made regarding DI or DLO techniques owing to the paucity of evidence. Secondary outcomes including sexual function, and complications are infrequently reported. Recurrence rates deteriorate in the long term for both DO and VO procedures. We reviewed the evidence for four different skin-graft techniques used to repair narrowing of a section of the urethra (bulbar urethra, under the scrotum and perineum) in men. Two of the techniques seem to give consistent results, with recurrence rates lower than 20%. Recurrence rates increase over time, so patients should continue to monitor their symptoms. There is poorer reporting of other outcomes such as sexual function, urinary symptoms, and complications, and it is possible that these occur more frequently than the current data suggest.

Identifiants

pubmed: 33875306
pii: S0302-2838(21)00232-3
doi: 10.1016/j.eururo.2021.03.026
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-68

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Rachel Barratt (R)

Department of Urology, University College London Hospital, London, UK. Electronic address: rachelbarratt@nhs.net.

Garson Chan (G)

Division of Urology, University of Saskatchewan, Saskatoon, Canada.

Roberto La Rocca (R)

Department of Urology, University of Naples Federico II, Naples, Italy.

Konstantinos Dimitropoulos (K)

Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.

Francisco E Martins (FE)

Department of Urology, Santa Maria University Hospital, University of Lisbon, Lisbon, Portugal.

Félix Campos-Juanatey (F)

Urology Department, Marques de Valdecilla University Hospital, Santander, Spain.

Tamsin J Greenwell (TJ)

Department of Urology, University College London Hospital, London, UK.

Marjan Waterloos (M)

Division of Urology, Gent University Hospital, Gent, Belgium.

Silke Riechardt (S)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nadir I Osman (NI)

Department of Urology, Sheffield Teaching Hospitals, Sheffield, UK.

Yuhong Yuan (Y)

Department of Medicine, Health Science Centre, McMaster University, Hamilton, ON, Canada.

Franceso Esperto (F)

Department of Urology, Campus Biomedico University of Rome.

Achilles Ploumidis (A)

Department of Urology, Athens Medical Centre, Athens, Greece.

Nicolaas Lumen (N)

Division of Urology, Gent University Hospital, Gent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH